Tower Research Capital (TRC)’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.8K | Buy |
|
|||||
|
2025
Q4 | $15.3K | Sell |
|
|||||
|
2025
Q3 | $22.6K | Sell |
|
|||||
|
2025
Q2 | $43.4K | Buy |
|
|||||
|
2025
Q1 | $18K | Buy |
|
|||||
|
2024
Q4 | $21.7K | Sell |
|
|||||
|
2024
Q3 | $127K | Buy |
|
|||||
|
2024
Q2 | $38.3K | Sell |
|
|||||
|
2024
Q1 | $214K | Buy |
|
|||||
|
2023
Q4 | $39.9K | Sell |
|
|||||
|
2023
Q3 | $150K | Buy |
|
|||||
|
2023
Q2 | $37.1K | Sell |
|
|||||
|
2023
Q1 | $70K | Buy |
|
|||||
|
2022
Q4 | $30K | Buy |
|
|||||
|
2022
Q3 | $22K | Sell |
|
|||||
|
2022
Q2 | $436K | Buy |
|
|||||
|
2022
Q1 | $289K | Buy |
|
|||||
|
2021
Q4 | $48K | Sell |
|
|||||
|
2021
Q3 | $75K | Sell |
|
|||||
|
2021
Q2 | $148K | Buy |
|
|||||
|
2021
Q1 | $32K | Buy |
|